These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12771857)

  • 1. Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tsaousi C; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2003 Mar; 22(1):55-7. PubMed ID: 12771857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.
    Barcellona D; Fenu L; Cauli C; Pisu G; Marongiu F
    Thromb Haemost; 2003 Dec; 90(6):1061-4. PubMed ID: 14652637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].
    Palomo I; Pereira J; Alarcón M; Pinochet C; Vélez MT; Hidalgo P; Skagerberg K; Poblete F
    Rev Med Chil; 2005 Dec; 133(12):1425-33. PubMed ID: 16446869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PORtromb Project: prothrombin G20210A mutation and venous thromboembolism in young people.
    Mansilha A; Araújo F; Sampaio S; Cunha Ribeiro LM; Braga A
    Cardiovasc Surg; 2002 Feb; 10(1):45-8. PubMed ID: 11790575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.
    Jun ZJ; Ping T; Lei Y; Li L; Ming SY; Jing W
    Clin Lab Haematol; 2006 Apr; 28(2):111-6. PubMed ID: 16630215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism.
    Folsom AR; Cushman M; Tsai MY; Heckbert SR; Aleksic N
    Am J Hematol; 2002 Dec; 71(4):285-90. PubMed ID: 12447958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.
    De Stefano V; Rossi E; Paciaroni K; D'Orazio A; Cina G; Marchitelli E; Pepe R; Leone G
    Haematologica; 2003 Jan; 88(1):61-6. PubMed ID: 12551828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of G20210A prothrombin gene mutation in Poland].
    Bykowska K; Vertun-Baranowska B; Windyga J; Łopaciuk S
    Pol Arch Med Wewn; 2000 Nov; 104(5):729-33. PubMed ID: 11434083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study.
    Dowling NF; Austin H; Dilley A; Whitsett C; Evatt BL; Hooper WC
    J Thromb Haemost; 2003 Jan; 1(1):80-7. PubMed ID: 12871543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
    Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease.
    Couturaud F; Oger E; Abalain JH; Chenu E; Guias B; Floch HH; Mercier B; Mottier D; Leroyer C
    Respiration; 2000; 67(6):657-61. PubMed ID: 11124649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism.
    Bonduel M; Hepner M; Sciuccati G; Pieroni G; Feliú-Torres A; Mardaraz C; Frontroth JP
    Thromb Haemost; 2002 Jun; 87(6):972-7. PubMed ID: 12083504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
    Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
    Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.
    Ramacciotti E; Wolosker N; Puech-Leao P; Zeratti EA; Gusson PR; del Giglio A; Franco RF
    Thromb Res; 2003 Feb; 109(4):171-4. PubMed ID: 12757770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.